Korro Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	91.15	166.15	36.33	83.49
Short-Term Investments	66.28	-	18.92	35.04
Cash & Short-Term Investments	157.43	166.15	55.25	118.53
Cash Growth	160.96%	200.73%	-53.39%	-
Prepaid Expenses	4.43	3.02	1.23	0.64
Restricted Cash	1.77	3.56	0.6	0.6
Total Current Assets	163.63	172.73	57.08	119.78
Property, Plant & Equipment	49.54	42.82	11.89	6.45
Other Long-Term Assets	6.08	6.12	4.77	1.35
Total Assets	249.59	221.66	73.74	127.58
Accounts Payable	5.69	7.28	2.61	0.79
Accrued Expenses	5.68	9.82	3.18	3.22
Current Portion of Leases	0.46	1.99	2.92	-
Other Current Liabilities	0.5	0.4	-	0.94
Total Current Liabilities	12.32	19.48	8.7	4.95
Long-Term Leases	38	31.22	0.21	-
Other Long-Term Liabilities	1.18	1.05	-	0.97
Total Liabilities	51.51	51.75	8.91	5.92
Common Stock	0.01	0.01	-	0.01
Additional Paid-In Capital	422.44	352.91	2.81	1.6
Retained Earnings	-224.39	-183.01	-101.83	-43.8
Comprehensive Income & Other	0.02	-	-0.01	-0.01
Total Common Equity	198.08	169.91	-99.03	-42.21
Shareholders' Equity	198.08	169.91	64.83	121.66
Total Liabilities & Equity	249.59	221.66	73.74	127.58
Total Debt	38.46	33.21	3.13	-
Net Cash (Debt)	149.32	132.94	52.12	118.53
Net Cash Growth	376.65%	155.08%	-56.03%	-
Net Cash Per Share	26.46	86.93	204.24	26.65
Filing Date Shares Outstanding	9.3	8.02	5.65	4.45
Total Common Shares Outstanding	9.28	8.02	5.4	4.45
Working Capital	151.3	153.25	48.38	114.83
Book Value Per Share	21.34	21.20	-18.33	-9.49
Tangible Book Value	198.08	169.91	-99.03	-42.21
Tangible Book Value Per Share	21.34	21.20	-18.33	-9.49
Machinery	12.28	11.91	9.13	4.68
Construction In Progress	18.35	8.24	2.05	0.63
Leasehold Improvements	3.36	3.36	2.94	2.88

Source: S&P Capital IQ. Standard template. Financial Sources.